公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | SDF-1/CXCR4 Signaling Maintains Stemness Signature in Mouse Neural Stem/Progenitor Cells | Ho, Shih-Yin; THAI-YEN LING ; Lin, Hsing-Yu; Liou, Jeffrey Tsai-Jui; Liu, Fei-Chih; Chen, I-Chun; Lee, Sue-Wei; Hsu, Yu; DAR-MING LAI ; HORNG-HUEI LIOU | Stem Cells International | 32 | 32 | |
2001 | Seizure frequency affects event-related potentials (P300) in epilepsy | Chen R.-C.; Tsai S.-Y.; Chang Y.-C.; HORNG-HUEI LIOU | Journal of Clinical Neuroscience | 12 | 12 | |
2009 | Sibutramine-induced recurrent seizures | Huang B.-C.; HORNG-HUEI LIOU | Epilepsy and Behavior | 3 | 2 | |
2007 | Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14) | Hsu W.-C.; Chiu Y.-H.; Chen W.-H.; Chiu H.-C.; HORNG-HUEI LIOU ; Chen, Tony Hsiu Hsi | Neuroepidemiology | 10 | 9 | |
2015 | Structural basis for cooperative oxygen binding and bracelet-assisted assembly of Lumbricus terrestris hemoglobin | Chen W.-T.; Chen Y.-C.; HORNG-HUEI LIOU ; Chao C.-Y. | Scientific Reports | 9 | 8 | |
2003 | Structural Basis of Binding and Inhibition of Novel Tarantula Toxins in Mammalian Voltage-Dependent Potassium Channels | Shiau Y.-S.; Huang P.-T.; HORNG-HUEI LIOU ; Liaw Y.-C.; Shiau Y.-Y.; KUO-LONG LOU | Chemical Research in Toxicology | 35 | 31 | |
2002 | Structural determinants and specificities for ROMK1-phosphoinositide interaction | Zeng W.-Z.; HORNG-HUEI LIOU ; Murali Krishna U.; Falck J.R.; Huang C.-L. | American Journal of Physiology - Renal Physiology | 35 | 31 | |
2002 | Structural influence of hanatoxin binding on the carboxyl terminus of S3 segment in voltage-gated K+-channel Kv2.1 | Huang P.T.; Chen T.Y.; Tseng L.J.; KUO-LONG LOU ; HORNG-HUEI LIOU ; Lin T.B.; Spatz H.C.; Shiau Y.Y. | Receptors and Channels | 11 | 13 | |
2002 | Subthalamotomy for advanced Parkinson disease | Su P.C.; Tseng H.-M.; HON-MAN LIU ; RUOH-FANG YEN ; HORNG-HUEI LIOU | Journal of Neurosurgery | 48 | 42 | |
2013 | Theory of mind in patients with temporal lobe epilepsy | Li Y.-H.; MING-JANG CHIU ; Yeh Z.-T.; HORNG-HUEI LIOU ; Cheng T.-W.; Hua M.-S. | Journal of the International Neuropsychological Society | 37 | 35 | |
2003 | Treatment of advanced Parkinson's disease by subthalamotomy: One-year results | Su P.C.; Tseng H.-M.; HON-MAN LIU ; RUOH-FANG YEN ; HORNG-HUEI LIOU | Movement Disorders | 65 | 44 | |
2005 | Two-stage community-based screening model for estimating prevalence of diabetic polyneuropathy (KCIS No. 6) | Hsu W.-C.; Chiu Y.-H.; Chiu H.-C.; HORNG-HUEI LIOU ; Jeng Y.-C.; Chen, Tony Hsiu Hsi | Neuroepidemiology | 13 | 9 | |
2011 | YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway | Hung C.-C.; HORNG-HUEI LIOU | Investigational New Drugs | 18 | 18 |